Related Experiment Video
Updated: Jun 20, 2026
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Novel approaches to inhibiting HIV-1 replication.
Catherine S Adamson1, Eric O Freed
1Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, MD 21702-1201, USA.
Antiviral Research
|September 29, 2009
Summary
New antiretroviral drugs are needed to combat HIV-1 resistance and treatment failure. This review highlights novel targets in the viral replication cycle for future drug discovery efforts.
Area of Science:
- Virology
- Drug Discovery
- Molecular Biology
Background:
- HIV-1 treatment has advanced significantly with numerous antiretroviral drugs.
- However, drug resistance, toxicity, and adherence issues necessitate novel therapeutic strategies.
Purpose of the Study:
- To identify and discuss promising novel targets for HIV-1 drug discovery.
- To review the molecular and cellular biology relevant to these targets.
- To summarize progress in developing inhibitors against these new targets.
Main Methods:
- Literature review of HIV-1 replication cycle and drug development.
- Analysis of molecular and cell biology of novel target sites.
- Discussion of current progress in inhibitor development.
Main Results:
- Several novel targets in the HIV-1 replication cycle are identified.
- These include lipid rafts, RNase H activity, uncoating, integration machinery, assembly, maturation, budding, and accessory proteins.
- Progress in developing inhibitors against these targets is reviewed.
Conclusions:
- Continued research into novel antiretroviral targets is crucial for overcoming treatment challenges.
- Developing inhibitors against these new targets holds promise for future HIV-1 therapy.
- This review provides an overview of promising avenues for next-generation antiretroviral drug development.
Related Concept Videos
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...